| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA1827110 | A | Cytotoxicity against human HEL cells at 100 ug/ml | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 2. | ALA1827111 | A | Cytotoxicity against african green monkey Vero cells at 100 ug/ml | Chlorocebus sabaeus | 5 | cell-based format | Scientific Literature | ||
| 3. | ALA1827112 | A | Cytotoxicity against human HeLa cells at 100 ug/ml | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 4. | ALA1827113 | A | Cytotoxicity against human CEM cells at 100 ug/ml | Homo sapiens | 5 | cell-based format | Scientific Literature | ||
| 5. | ALA1827114 | A | Cytotoxicity against MDCK cells at 100 ug/ml | Canis lupus familiaris | 5 | cell-based format | Scientific Literature | ||
| 6. | ALA1827115 | A | Cytotoxicity against CRFK cells at 100 ug/ml | Felis catus | 5 | cell-based format | Scientific Literature | ||
| 7. | ALA1827116 | F | Antiviral activity against Human immunodeficiency virus 1 3B infected in human CEM cells assessed as inhibition of virus-induced giant cell formation after 4 days by microscopic method | Human immunodeficiency virus 1 | 5 | organism-based format | Scientific Literature | ||
| 8. | ALA1827117 | F | Antiviral activity against Human immunodeficiency virus type 2 ROD infected in human CEM cells assessed as inhibition of virus-induced giant cell formation after 4 days by microscopic method | Human immunodeficiency virus 2 | 5 | organism-based format | Scientific Literature | ||
| 9. | ALA1827118 | F | Antiviral activity against Human cytomegalovirus infected in human HEL cells assessed as inhibition of virus-induced cytopathicity upto 200 uM administered after 1 hr virus adsorption period | Human betaherpesvirus 5 | 5 | organism-based format | Scientific Literature | ||
| 10. | ALA1827119 | F | Antiviral activity against Varicella Zoster Virus infected in human HEL cells assessed as inhibition of virus-induced cytopathicity upto 200 uM administered after 1 hr virus adsorption period | Human alphaherpesvirus 3 | 5 | organism-based format | Scientific Literature | ||
| 11. | ALA1827120 | F | Antiviral activity against influenza A virus H1N1 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity upto 200 uM administered after 1 hr virus adsorption period | Influenza A virus | 5 | organism-based format | Scientific Literature | ||
| 12. | ALA1827121 | F | Antiviral activity against Influenza A virus H3N2 infected in MDCK cells assessed as inhibition of virus-induced cytopathicity upto 200 uM administered after 1 hr virus adsorption period | Influenza A virus H3N2 | 5 | organism-based format | Scientific Literature | ||
| 13. | ALA1827122 | F | Antiviral activity against influenza B virus infected in MDCK cells assessed as inhibition of virus-induced cytopathicity upto 200 uM administered after 1 hr virus adsorption period | Influenza B virus | 5 | organism-based format | Scientific Literature | ||
| 14. | ALA1827123 | F | Antiviral activity against Feline coronavirus infected in CRFK cells assessed as inhibition of virus-induced cytopathicity upto 200 uM administered after 1 hr virus adsorption period | Feline coronavirus | 5 | organism-based format | Scientific Literature | ||
| 15. | ALA1827124 | F | Antiviral activity against Herpes simplex virus type 1 infected in HEL cells assessed as inhibition of virus-induced cytopathicity upto 200 uM administered after 1 hr virus adsorption period | Human alphaherpesvirus 1 | 5 | organism-based format | Scientific Literature | ||
| 16. | ALA1827125 | F | Antiviral activity against Herpes simplex virus type 2 infected in HEL cells assessed as inhibition of virus-induced cytopathicity upto 200 uM administered after 1 hr virus adsorption period | Human alphaherpesvirus 2 | 5 | organism-based format | Scientific Literature | ||
| 17. | ALA1827126 | F | Antiviral activity against Vesicular stomatitis virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity upto 200 uM administered after 1 hr virus adsorption period | Vesicular stomatitis virus | 5 | organism-based format | Scientific Literature | ||
| 18. | ALA1827415 | F | Antiviral activity against Vaccinia virus infected in HEL cells assessed as inhibition of virus-induced cytopathicity upto 200 uM administered after 1 hr virus adsorption period | Vaccinia virus | 5 | organism-based format | Scientific Literature | ||
| 19. | ALA1827416 | F | Antiviral activity against Coxsackievirus B4 infected in HeLa cells assessed as inhibition of virus-induced cytopathicity upto 200 uM administered after 1 hr virus adsorption period | Coxsackievirus B4 | 5 | organism-based format | Scientific Literature | ||
| 20. | ALA1827417 | F | Antiviral activity against Respiratory syncytial virus infected in HeLa cells assessed as inhibition of virus-induced cytopathicity upto 200 uM administered after 1 hr virus adsorption period | Respiratory syncytial virus | 5 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!